Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CAI Caris Life Sciences, Inc.

Market Closed 06-18 16:00:00 EDT

18.47

+0.61

+3.42%

盘后18.50

+0.03+0.14%

19:00 EDT

High18.52	Low17.76	Vol2.40M
Open18.17	D1 Closing17.86	Amplitude4.23%
Mkt Cap5.21B	Tradable Cap1.70B	Total Shares282.15M
T/O43.98M	T/O Rate2.61%	Tradable Shares91.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CAI","market":"US","secType":"STK","nameCN":"Caris Life Sciences, Inc.","latestPrice":18.47,"timestamp":1781812800000,"preClose":17.86,"halted":0,"volume":2398379,"hourTrading":{"tag":"盘后","latestPrice":18.4959,"preClose":18.47,"latestTime":"19:00 EDT","volume":294221,"amount":5434306.0214,"timestamp":1781823644612,"change":0.0259,"changeRate":0.001402,"amplitude":0.001402},"delay":0,"changeRate":0.03415453527435607,"floatShares":91917486,"shares":282146923,"eps":-1.456,"marketStatus":"Market Closed","change":0.61,"latestTime":"06-18 16:00:00 EDT","open":18.17,"high":18.515,"low":17.76,"amount":43980205.359509,"amplitude":0.042273,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.456,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1750219200000,"exchange":"NASDAQ","adjPreClose":17.86,"preHourTrading":{"tag":"盘前","latestPrice":18.25,"preClose":17.86,"latestTime":"09:24 EDT","volume":466,"amount":8471.440096,"timestamp":1781789076902,"change":0.39,"changeRate":0.021837,"amplitude":0.013998},"postHourTrading":{"tag":"盘后","latestPrice":18.4959,"preClose":18.47,"latestTime":"19:00 EDT","volume":294221,"amount":5434306.0214,"timestamp":1781823644612,"change":0.0259,"changeRate":0.001402,"amplitude":0.001402},"volumeRatio":1.1869714097228001,"impliedVol":0.8451,"impliedVolPercentile":0.752},"requestUrl":"/m/hq/s/CAI/tweets","defaultTab":"tweets","newsList":[{"id":"2643752420","title":"Caris Life Sciences to add NYSE Texas dual listing June 17 under CAI ticker","url":"https://stock-news.laohu8.com/highlight/detail?id=2643752420","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643752420?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:31","pubTimestamp":1781613096,"startTime":"0","endTime":"0","summary":"Caris Life Sciences will add a secondary listing on NYSE Texas effective June 17, 2026.Shares will remain primarily listed on Nasdaq; the NYSE Texas listing will use the same CAI ticker.The move targets broader investor exposure, with added visibility in Texas.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL1Qtr8z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643675248","title":"Caris Life Sciences Announces Dual Listing on Nyse Texas","url":"https://stock-news.laohu8.com/highlight/detail?id=2643675248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643675248?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:30","pubTimestamp":1781613007,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUA9J1XFG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4104","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643224968","title":"CAI Corp Reports Unaudited Net Asset Value of HK$0.14 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2643224968","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643224968?lang=en_us&edition=fundamental","pubTime":"2026-06-15 12:07","pubTimestamp":1781496470,"startTime":"0","endTime":"0","summary":"The latest announcement is out from China New Economy Fund Ltd. ( ($HK:0080) ). CAI Corp has reported an unaudited net asset value of approximately...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-of-hk0-14-per-share-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-of-hk0-14-per-share-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4104","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642415688","title":"Insiders At CAI See Good Returns After Buying Stock Worth HK$311.8m","url":"https://stock-news.laohu8.com/highlight/detail?id=2642415688","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642415688?lang=en_us&edition=fundamental","pubTime":"2026-06-10 06:59","pubTimestamp":1781045992,"startTime":"0","endTime":"0","summary":"Insiders who bought CAI Corp ( HKG:80 ) stock lover the last 12 months are probably not as affected by last week’s 11...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/diversified-financials/hkg-80/cai-shares/news/insiders-at-cai-see-good-returns-after-buying-stock-worth-hk","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/diversified-financials/hkg-80/cai-shares/news/insiders-at-cai-see-good-returns-after-buying-stock-worth-hk","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CAI","00080","BK4139","BK4104","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141804459","title":"Caris Life Sciences Board Approves $100 Million Share Buyback Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=1141804459","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141804459?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:40","pubTimestamp":1780929636,"startTime":"0","endTime":"0","summary":"The precision medicine company Caris Life Sciences, Inc. (NASDAQ: CAI) announced on June 8 that its board of directors has authorized a new share repurchase program for up to $100 million of its...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641484308","title":"Caris Life Sciences launches USD 100 million share buyback program","url":"https://stock-news.laohu8.com/highlight/detail?id=2641484308","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641484308?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:31","pubTimestamp":1780921907,"startTime":"0","endTime":"0","summary":"Caris Life Sciences launched a share repurchase program of up to USD 100 million for its outstanding common stock.Buybacks may be executed in the open market or via privately negotiated transactions, including Rule 10b5-1 trading plans.The program has no expiration date. It can be modified, suspended, or ended at the board’s discretion.Repurchases are expected to be funded from available cash and cash equivalents.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via PR Newswire  on June 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDLcdJ7JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641843494","title":"Caris Life Sciences - Company Expects to Fund Repurchase Program From Available Cash and Cash Equivalents","url":"https://stock-news.laohu8.com/highlight/detail?id=2641843494","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641843494?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:30","pubTimestamp":1780921802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA1C88ZK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAI","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641313484","title":"Caris Life Sciences Announces Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2641313484","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641313484?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:30","pubTimestamp":1780921802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA1C88ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CAI","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640948406","title":"Caris Life Sciences Coverage Assumed by Wolfe Research at Peer Perform","url":"https://stock-news.laohu8.com/highlight/detail?id=2640948406","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640948406?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:26","pubTimestamp":1780403160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CAI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2026 08:26 ET (12:26 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640962669","title":"Caris Life Sciences assumed at Peer Perform from Outperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2640962669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640962669?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:23","pubTimestamp":1780345439,"startTime":"0","endTime":"0","summary":"Wolfe Research analyst Mike Polark downgraded Caris Life Sciences (CAI) to Peer Perform from Outperform with no price target as the analyst assumed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-assumed-at-peer-perform-from-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-assumed-at-peer-perform-from-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637406312","title":"Caris studies MSH3 loss impact on immune checkpoint outcomes across cancers at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637406312","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637406312?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:25","pubTimestamp":1779456354,"startTime":"0","endTime":"0","summary":"Caris Life Sciences outlined 32 retrospective, real-world studies slated for presentation at the 2026 ASCO Annual Meeting in Chicago on May 29–June 2, including one rapid oral session on MSH3 loss-of-function alterations in patients treated with immune checkpoint blockade across cancer types.One Caris-led analysis links genetic ancestry to ultraviolet-related mutational patterns in melanoma, positioning the signal as a potential way to refine immunotherapy response assessment beyond standard mutation-based approaches.A separate Caris-led study identifies ESR1 amplification in breast cancer as a distinct genomic subtype tied to poorer outcomes and reduced benefit from CDK4/6 inhibitor therapy, a finding that could influence patient stratification in a major commercial treatment class.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for info","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL9nQl1K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637311213","title":"Cloud AI Update - CAI Boosts Multicloud Integration With AWS And Microsoft Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2637311213","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637311213?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:08","pubTimestamp":1779451730,"startTime":"0","endTime":"0","summary":"CAI, a global services firm, has announced strategic partnerships with Amazon Web Services (AWS) and Microsoft to enhance multicloud integration, aiming to support public sector and enterprise clients in modernizing their IT infrastructure. By collaborating with Anthropic, Databricks, and LMNTRIX, CAI seeks to deliver a comprehensive cloud solution that integrates security and AI capabilities across AWS and Azure environments. This multicloud strategy is designed to help organizations avoid...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/21835-main-header/1756191612247","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/21835-main-header/1756191612247"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-msft/microsoft/news/cloud-ai-update-cai-boosts-multicloud-integration-with-aws-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-msft/microsoft/news/cloud-ai-update-cai-boosts-multicloud-integration-with-aws-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CAI","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635846774","title":"CAI Corp Reports Unaudited Net Asset Value of HK$0.14 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2635846774","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635846774?lang=en_us&edition=fundamental","pubTime":"2026-05-15 12:08","pubTimestamp":1778818111,"startTime":"0","endTime":"0","summary":"China New Economy Fund Ltd. ( ($HK:0080) ) has provided an announcement. CAI Corp, a Cayman Islands-incorporated company listed on the Hong Kong St...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-of-hk0-14-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cai-corp-reports-unaudited-net-asset-value-of-hk0-14-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4104","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635794420","title":"Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Caris Life Sciences, Inc. (CAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635794420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635794420?lang=en_us&edition=fundamental","pubTime":"2026-05-14 16:20","pubTimestamp":1778746835,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Crispr Therapeutics AG (CRSP) and Caris Life Science...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-crispr-therapeutics-ag-crsp-caris-life-sciences-inc-cai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-crispr-therapeutics-ag-crsp-caris-life-sciences-inc-cai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI","BLSG","LU1861559042.SGD","LU1861558580.USD","LABU","BK4139","BK4137","BK4556","BK4104","LU0128526141.USD","LU0029874061.USD","BK4611","BK4112","BK4581","XBI","BK4210","BK4585","CRSP","BLSX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635220266","title":"Caris Life Sciences Director Makes Bold Insider Move With Major Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2635220266","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635220266?lang=en_us&edition=fundamental","pubTime":"2026-05-13 10:12","pubTimestamp":1778638358,"startTime":"0","endTime":"0","summary":"New insider activity at Caris Life Sciences, Inc. ( ($CAI) ) has taken place on May 12, 2026. Director Jeff L Vacirca has demonstrated confidence i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/caris-life-sciences-director-makes-bold-insider-move-with-major-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/caris-life-sciences-director-makes-bold-insider-move-with-major-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145960259","title":"Stock Track | Caris Life Sciences Soars 5.08% Intraday on Director Share Purchase and Analyst Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1145960259","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145960259?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:59","pubTimestamp":1778594347,"startTime":"0","endTime":"0","summary":"Caris Life Sciences, Inc. (CAI) saw its stock price soar 5.08% during Tuesday's intraday trading session.The surge follows a regulatory filing showing that company director Jeff L. Vacirca purchased...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634194712","title":"Caris director Jeff L Vacirca acquires 31,050 shares for $501,426.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2634194712","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634194712?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:23","pubTimestamp":1778588593,"startTime":"0","endTime":"0","summary":"Caris Life Sciences director Jeff L. Vacirca reported a purchase of 31,050 common shares at USD 16.15 per share.Directly held stake rose to 49,671 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Caris Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL1H22bJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Caris director Jeff L Vacirca acquires 31,050 shares for $501,426.95","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215754","title":"Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215754?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:31","pubTimestamp":1778585477,"startTime":"0","endTime":"0","summary":"In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on Caris Life Sciences, Inc., with a price target of $21.0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/caris-life-sciences-inc-cai-gets-a-hold-from-piper-sandler-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/caris-life-sciences-inc-cai-gets-a-hold-from-piper-sandler-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","CAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634471239","title":"Caris Life Sciences announces publication of study on measuring TMB using WES","url":"https://stock-news.laohu8.com/highlight/detail?id=2634471239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634471239?lang=en_us&edition=fundamental","pubTime":"2026-05-12 01:55","pubTimestamp":1778522147,"startTime":"0","endTime":"0","summary":"Caris Life Science has published a study in Cancer Immunology, Immunotherapy demonstrating that measuring tumor mutational burden using ultra-deep ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-announces-publication-of-study-on-measuring-tmb-using-wes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-announces-publication-of-study-on-measuring-tmb-using-wes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAI","WES","BK4144","BK4590","BK4139","TMB","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634323519","title":"Caris study finds whole exome TMB predicts pembrolizumab survival better than gene panels","url":"https://stock-news.laohu8.com/highlight/detail?id=2634323519","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634323519?lang=en_us&edition=fundamental","pubTime":"2026-05-12 00:15","pubTimestamp":1778516124,"startTime":"0","endTime":"0","summary":"Caris Life Sciences published a study in Cancer Immunology, Immunotherapy showing whole exome sequencing-based measurement of tumor mutational burden better identified patients likely to benefit from pembrolizumab than estimates derived from targeted gene panels.Findings were published with no separate conference presentation disclosed.Analysis of 26,756 pembrolizumab-treated patients found targeted panels sometimes misclassified patients, which could shift immunotherapy eligibility decisions.In cases where panel estimates diverged from whole exome results, whole exome-based assessment aligned more closely with improved survival outcomes.Results support broader adoption of whole exome sequencing in therapy selection, reinforcing commercial positioning of its FDA-cleared MI Cancer Seek assay that reports tumor mutational burden.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL5lHptV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAI","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carislifesciences.com","stockEarnings":[{"period":"1week","weight":0.0261},{"period":"1month","weight":0.2346},{"period":"3month","weight":0.0033},{"period":"6month","weight":-0.3389},{"period":"1year","weight":-0.3404},{"period":"ytd","weight":-0.3154}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Caris Life Sciences, Inc. is a leading patient-centered next-generation artificial intelligence technology biology company and precision medicine pioneer. It develops and commercializes innovative solutions to transform health care through the large-scale use of comprehensive molecular information and AI/ML algorithms. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology and serving the clinical, academic and biopharmaceutical markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":0.003709},{"month":2,"riseRate":0.714286,"avgChangeRate":0.097096},{"month":3,"riseRate":0.785714,"avgChangeRate":0.045627},{"month":4,"riseRate":0.642857,"avgChangeRate":0.069907},{"month":5,"riseRate":0.571429,"avgChangeRate":0.009049},{"month":6,"riseRate":0.4,"avgChangeRate":0.003897},{"month":7,"riseRate":0.533333,"avgChangeRate":0.001503},{"month":8,"riseRate":0.466667,"avgChangeRate":0.000804},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.003567},{"month":10,"riseRate":0.666667,"avgChangeRate":0.042552},{"month":11,"riseRate":0.533333,"avgChangeRate":0.007248},{"month":12,"riseRate":0.4,"avgChangeRate":-0.027079}],"exchange":"NASDAQ","name":"Caris Life Sciences, Inc.","nameEN":"Caris Life Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Caris Life Sciences, Inc.(CAI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Caris Life Sciences, Inc.,CAI,Caris Life Sciences, Inc.股票,Caris Life Sciences, Inc.股票老虎,Caris Life Sciences, Inc.股票老虎国际,Caris Life Sciences, Inc.行情,Caris Life Sciences, Inc.股票行情,Caris Life Sciences, Inc.股价,Caris Life Sciences, Inc.股市,Caris Life Sciences, Inc.股票价格,Caris Life Sciences, Inc.股票交易,Caris Life Sciences, Inc.股票购买,Caris Life Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caris Life Sciences, Inc.(CAI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Caris Life Sciences, Inc.(CAI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}